dalbavancin [Antibiotic]

Download Sequences

Accession ARO:3000466
DefinitionDalbavancin is a semisynthetic second-generation lipoglycopeptide derived from teicoplanin. It binds to the D-Ala-D-Ala terminus of peptidoglycan precursors. It is used to treat Gram-positive bacteria and can be used to treat methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Drug Classglycopeptide antibiotic
Classification2 ontology terms | Show
Parent Term(s)1 ontology terms | Show
1 ontology terms | Show
+ acyl-D-alanyl-D-alanine targeted_by_antibiotic

Kim A, et al. 2007. Expert Opin Investig Drugs 16(5): 717-733. Review of dalbavancin, a novel semisynthetic lipoglycopeptide. (PMID 17461743)

Guay DR. 2004. Expert Rev Anti Infect Ther 2(6): 845-852. Dalbavancin: an investigational glycopeptide. (PMID 15566329)

Tatarkiewicz J, et al. 2016. Arch Med Sci 12(6):1327-1336 New agents approved for treatment of acute staphylococcal skin infections. (PMID 27904526)